Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.

Details

Language :

English

ISSN :

0732183X

Volume :

28

Issue :

5

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105316841

Full Text :

https://doi.org/10.1200/JCO.2009.23.1704